Redhill Biopharma RDHL 深 沪
交易中 09-04 11:29:52 美东时间
0.7245
+0.012
+1.64%
华盛通- 最 高0.7429
- 今 开0.74
- 成交量 14.88万股
- 最 低 0.6997
- 昨 收 0.7128
- 总市值 440.56万
- 52周最高 2.79
- 市盈率 静 --
- 换手率 2.45%
- 52周最低 0.57
- 委 比 66.67%
- 总股本 608.09万
- 历史最高 22220.00
- 量 比 0.03
- 振 幅 6.06%
- 历史最低 0.57
- 每 手 1
- 风险率 0.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
Together with the previously announced Talicia® strategic divestiture, the acquisition from Ferring of commercialization rights to two larger, proprietary, established gastrointestinal (GI) ...
09-01 19:00
Market-Moving News for August 31st
EIX: -10% | Edison International shares are trading lower following a report suggesting that California lawmakers have blocked Gov. Gavin Newsom from pursuing his plan to prevent insurance companies in California from recouping their losses from investor-owned utilities that cause a catastrophic wil...
08-31 19:38
Redhill Biopharma Divests Talicia Business To Apotex Health Subsidiary For An Upfront Payment Of $18M Plus Up To An Additional $35M In Potential Sales-based Milestone Payments
Executes a major step in RedHill's strategic roadmap to fundamentally reposition the Company's commercial business toward new and larger product opportunities, revenue growth and an accelerated path toward operational profitability -- Realizes substantial value from RedHill's 70% stake in Talicia, c...
08-31 19:03
RedHill Biopharma Announces Up To $19.4 Million Private Placement
$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in full of warrants TEL AVIV, Israel & RALEIGH, N.C., June 18, 2026 /PRNewsw...
06-18 20:00
美股夜盘 | Everbright Digital Holding Ltd.涨52.51%，维珍银河涨13.44%
Sky Quarry, Inc.涨-8.90%；Tianci International Inc涨-6.96%；RedHill Biopharma Ltd. Sponsored ADR涨-5.66%
06-12 08:05
RedHill Biopharma shares are trading lower. The company announced the FDA has granted rare pediatric disease designation to opaganib for treatment of neuroblastoma.
RedHill Biopharma shares are trading lower. The company announced the FDA has g...
06-09 22:14
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Regentis Biomaterials (AMEX:RGNT) stock rose 128.9% to $2.93 during Tu...
06-09 20:05
RedHill Biopharma Actively Discussing Potential Collaborations For Advancement Of Its Investigational Oral Drug, Opaganib, To Combat Ebola Virus Disease
Amid the rapidly evolving Ebola virus disease (EVD) outbreak involving the rare Bundibugyo ebolavirus sub-type, for which there are no approved medications or vaccines, RedHill Biopharma is actively discussing potential
06-02 20:10
Redhill Biopharma Announces New In Vitro Testing Results Demonstrating RHB-204's Comparability To RHB-104 In Mycobacterium Avium Subspecies Paratuberculosis Killing Efficacy
RHB-2041 is a next-generation optimized formulation of RedHill's oral RHB-1042, designed for enhanced tolerability, safety profile and patient adherence, that employs a groundbreaking Mycobacterium avium subspecies
04-30 19:12
Redhill Biopharma FY EPS $0.00, Sales $286.000K Down From $8.043M YoY
Redhill Biopharma (NASDAQ:RDHL) reported quarterly earnings of $0.00 per share. The company reported $286.000 thousand in sales this quarter. This is a 96.44 percent decrease over sales of $8.043 million the same period
04-27 20:14
